Position in NVS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$313,753
+$30,984 QoQ
Shares Held
2,002
-9.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,105
of 1,603 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gimbal Financial holds $13,428,466 across 5 Drug Manufacturers - General names. NVS ranks #5 (2.3% of the industry book) .
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313,753 | 2,002 | Shares | Sole | 2026-08-04 | |
| 2025-09-30 | $282,769 | 2,205 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $266,827 | 2,205 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $245,590 | 2,203 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $214,373 | 2,203 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $253,389 | 2,203 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $239,109 | 2,246 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $216,965 | 2,243 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $226,475 | 2,243 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||